Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | HES1 |
| Upstream (Parents) |
|---|
| (<<) ACTB → HES1 |
| (<<) ANXA2 → HES1 |
| (<<) BCL2L1 → HES1 |
| (<<) CFL1 → HES1 |
| (<<) CYB5R3 → HES1 |
| (<<) ENO1 → HES1 |
| (<<) GAPDH → HES1 |
| (<<) GPX4 → HES1 |
| (<<) HSPB1 → HES1 |
| (<<) PPIB → HES1 |
| (<<) RAB5B → HES1 |
| (<<) RAC3 → HES1 |
| (<<) RHOA → HES1 |
| (<<) RHOB → HES1 |
| (<<) RHOC → HES1 |
| (<<) ROCK2 → HES1 |
| (<<) RPL35 → HES1 |
| (<<) RPL36 → HES1 |
| (<<) RPS16 → HES1 |
| (<<) RTN3 → HES1 |
| (<<) STAT2 → HES1 |
| (<<) TAGLN2 → HES1 |
| (<<) TUBB2C → HES1 |
| (<<) YWHAE → HES1 |
| (<<) YWHAH → HES1 |
| Downstream (Children) |
|---|
| HES1 → BCAM (>>) |
| HES1 → CASP3 (>>) |
| HES1 → CBL (>>) |
| HES1 → CDK7 (>>) |
| HES1 → CDR2 (>>) |
| HES1 → CEBPD (>>) |
| HES1 → CMTM7 (>>) |
| HES1 → CSNK1A1 (>>) |
| HES1 → CTSF (>>) |
| HES1 → DDX18 (>>) |
| HES1 → DUSP2 (>>) |
| HES1 → DUSP7 (>>) |
| HES1 → FUT4 (>>) |
| HES1 → GNAS (>>) |
| HES1 → GNE (>>) |
| HES1 → GPX3 (>>) |
| HES1 → GSK3B (>>) |
| HES1 → ID1 (>>) |
| HES1 → ITCH (>>) |
| HES1 → KCNJ2 (>>) |
| HES1 → MAPK1 (>>) |
| HES1 → MYO10 (>>) |
| HES1 → NCOA7 (>>) |
| HES1 → NFIL3 (>>) |
| HES1 → NUPR1 (>>) |
| HES1 → PABPC3 (>>) |
| HES1 → PDPK1 (>>) |
| HES1 → PLCG2 (>>) |
| HES1 → PNO1 (>>) |
| HES1 → PRNP (>>) |
| HES1 → RNASE4 (>>) |
| HES1 → SEPW1 (>>) |
| HES1 → SOD1 (>>) |
| HES1 → UBE2I (>>) |
| HES1 → UBE2J1 (>>) |
| HES1 → ZBED2 (>>) |
